Previous Article | Next Article ![]()
Journal of Bacteriology, August 2002, p. 4065-4070, Vol. 184, No. 15
0021-9193/02/$04.00+0 DOI: 10.1128/JB.184.15.4065-4070.2002
Copyright © 2002, American Society for Microbiology. All Rights Reserved.
Departments of Biochemistry,1 Biological Sciences, Purdue University, West Lafayette, Indiana 479072
Received 28 February 2002/ Accepted 29 April 2002
|
|
|---|
Ha was 6,000 cal. The pH activity profile, optimum activity at pH 9.8, yielded a pKa of 8.8 for a dissociating group, presumably Glu78. The stoichiometry per monomer of acetyl-CoA binding was 1.2 ± 0.2 and that of covalent acetylation was 0.60 ± 0.02. The Km for the hydrolysis of acetyl-CoA was 10 µM. Coupled conversion of acetyl-CoA to mevalonate was demonstrated by using HMG-CoA synthase and acetoacetyl-CoA thiolase/HMG-CoA reductase from E. faecalis. |
|
|---|
![]() View larger version (14K): [in a new window] |
FIG. 1. Intermediates and enzymes of the mevalonate pathway for IPP biosynthesis.
|
An unusual feature of the mevalonate pathway of Enterococcus faecalis is that a dual-function polypeptide, acetoacetyl-CoA thiolase/HMG-CoA reductase (11, 27), catalyzes the first and third reactions of the pathway (Fig. 1). The second reaction of the mevalonate pathway, the functionally irreversible condensation of acetoacetyl-CoA and acetyl-CoA to form HMG-CoA, is catalyzed by HMG-CoA synthase (EC 4.1.3.5). Our interest in E. faecalis HMG-CoA synthase, which appears to link the activities of the dual-function E. faecalis enzyme, reflects both the potential of the mevalonate pathway enzymes of enterococci as targets for antibiotics and the fact that no bacterial HMG-CoA synthase has previously been characterized.
|
|
|---|
Construction of the expression plasmid. The mvaS gene was PCR amplified from E. faecalis chromosomal DNA with primers that introduced an NdeI site (5'-CGTAAAGGAGTTAAACATATGACAATTGGG-3') and a BamHI site (5'-GAATCGGGGGATCCAAATACTTAGTTCG-3') at the ends of the amplified fragment. The 1,176-bp PCR fragment was cloned into NdeI/BamHI-cut pET28 in frame with the N-terminal histidine tag and thrombin cleavage site to give the expression plasmid MvaS-pET28-6H. The insert was sequenced by the Iowa State University DNA Sequencing Facility, Ames, to verify that no mutations had been introduced during PCR amplification.
Expression and purification of the gene product. Escherichia coli BL21(DE3) cells transformed with MvaS-pET28-6H were grown at 37°C, with shaking, on Luria-Bertani broth (22) containing 10 µg of kanamycin per ml. Cells harvested by centrifugation were washed with 0.9% saline, suspended in Buffer A (10 mM imidazole, 300 mM NaCl, 1 mM phenylmethylsulfonyl fluoride, 1 mM dithiothreitol, 20 mM HEPES; pH 8.0), and lysed in a French press. The supernatant liquid (cytosol) obtained after centrifugation of the cell lysate in a Beckman L8-70 ultracentrifuge (30,000 rpm, 60 min, 4°C) was applied to an Ni-NTA column. The column was washed with Buffer A and then eluted successively with 50 and 100 mM imidazole in Buffer A. Fractions with high activity were combined and stored in liquid nitrogen. Protein concentration was determined by the Bradford method (5).
Analytical ultracentrifugation. E. faecalis HMG-CoA synthase, i.e., 430 µl of a 1-mg/ml solution in 100 mM NaCl-10 mM Tris (pH 8.0), was loaded in a Beckman analytical ultracentrifuge cell with sapphire windows and an aluminum-filled epoxy centerpiece. The cell was placed in a Beckman Model XL-I centrifuge and allowed to come to thermal equilibrium at 20°C for 1 h. The sample was then spun at 50,000 rpm for 4 h. Rayleigh interference scans were taken at 1-min intervals.
HMG-CoA synthase activity. Determination of HMG-CoA synthase activity employed a Hewlett-Packard model 8452 diode array spectrophotometer with the cell compartment maintained at 37°C to monitor the change in absorbance at 302 nm that accompanies the acetyl-CoA-dependent disappearance of the enolate form of acetoacetyl-CoA (21). The standard assay medium included 500 µM acetyl-CoA, 20 µM acetoacetyl-CoA, 5.0 mM MgCl2, and 50 mM Tris (pH 9.75). Assays employed a final volume of 220 µl. One enzyme unit (eu) represents the disappearance in 1 min of 1 µmol of acetoacetyl-CoA. The reported data represent mean values for at least triplicate determinations.
Acetyl-CoA hydrolase activity. Acetyl-CoA hydrolase activity was determined by measuring the release of coenzyme A with DTNB [5,5'-dithiobis(2-nitrobenzoic acid)]. The assay employed a Hewlett-Packard model 8452 diode array spectrophotometer with the cell compartment maintained at 37°C to monitor the change in absorbance at 412 nm that accompanies the reaction of CoA with DTNB. The assay employed modifications of the procedures of Weitzman (26) and Miziorko et al. (19). Standard assay conditions consisted of 1 mM DTNB, 20 µM acetyl-CoA, and 50 mM Tris (pH 9.8) in a final volume of 220 µl. One eu represents the release in 1 min of 1 µmol of CoA. The reported data represent mean values for at least triplicate determinations.
|
|
|---|
![]() View larger version (39K): [in a new window] |
FIG. 2. SDS-PAGE of fractions obtained during purification of E. faecalis HMG-CoA synthase. Lane 1, prestained standards of the indicated molecular weight; lane 2, cell extract; lane 3, cytosol; lane 4, Ni-NTA fraction.
|
|
View this table: [in a new window] |
TABLE 1. Selected sequences and conserved residues of animal and bacterial HMG-CoA synthasesa
|
![]() View larger version (28K): [in a new window] |
FIG. 3. Sedimentation velocity ultracentrifugation of E. faecalis HMG-CoA synthase. (A) Sedimentation boundaries measured by using Rayleigh interference optics plotted against radial position. The data shown are for 25-min intervals and represent one-fifth of the data used in the analysis. The jagged lines represent the observed fringes, and the smooth lines represent the calculated best-fit distribution calculated by using Sedfit 8.3 and the Lamm equation model (23). (B) Best-fit c(s) sedimentation coefficient distribution, allowing for systematic time-invariant noise. The uncorrected values for the sedimentation coefficients for the minor and major peaks are 3.6 and 5.3 S, respectively.
|
Ha of 6,000 cal was calculated from the Arrhenius plot (Fig. 4, top [inset]). Activity was optimal at 2 mM MgCl2 (Fig. 4, middle). Neither 5 to 10 mM EDTA nor 2 to 10 mM KCl affected activity. Optimal activity occurred at pH 9.8 (Fig. 4, bottom). Modeling of the data for pH values from pH 8.5 to 9.25 gave an estimated value for the pKa of a dissociating group of 8.8.
![]() View larger version (13K): [in a new window] |
FIG. 4. Effect of temperature, MgCl2 concentration, and hydrogen ion concentration. (Top) Temperature. Assays were conducted at the indicated temperatures under otherwise standard conditions. The inset shows selected data shown as an Arrhenius plot. (Middle) MgCl2.Assays were conducted at the indicated concentrations of MgCl2 under otherwise standard conditions. (Bottom) Hydrogen ion concentration. Assays were conducted in 50 mM sodium acetate, 50 mM glycine, 50 mM Tris, and 50 mM 2-(N-morpholino)ethanesulfonic acid at the indicated pH under otherwise standard conditions.
|
|
View this table: [in a new window] |
TABLE 2. Kinetic constants for selected HMG-CoA synthases
|
![]() View larger version (11K): [in a new window] |
FIG. 5. Proposed mechanism for catalysis of the HMG-CoA synthase reaction. Active site residues of the avian mitochondrial enzyme include Glu95, Cys129, and His264. During the acetylation step, Cys129 attacks the carbonyl group of acetyl-CoA, forming an acetyl-S-intermediate (17). After the addition and condensation of acetoacetyl-CoA, HMG-CoA is released by hydrolysis. Glu95 acts as the general acid in the condensation step (8), and His264 anchors binding of acetoacetyl-CoA (16).
|
|
View this table: [in a new window] |
TABLE 3. Parameters for the partial reactions that model the first and third stages of the overall reaction catalyzed by HMG-CoA synthase
|
Coupled conversion of acetyl-CoA to mevalonate. The first and third reactions of the mevalonate pathway in E. faecalis, the synthesis of acetoacetyl-CoA and the formation of mevalonate, are catalyzed by a single bifunctional enzyme (11). Since HMG-CoA synthase catalyzes the second reaction of the pathway, we investigated the coupled conversion of acetyl-CoA to mevalonate. The pH optima for HMG-CoA synthase, acetoacetyl-CoA thiolase, and HMG-CoA reductase range from pH 6.5 to 10.5. We therefore studied the coupled conversion of acetyl-CoA to mevalonate at several pH values. Coupled conversion was indeed observed. Optimal synthesis of mevalonate from acetyl-CoA occurred at pH 8.5 (Fig. 6).
![]() View larger version (25K): [in a new window] |
FIG. 6. Coupled conversion of acetyl-CoA to mevalonate catalyzed by E. faecalis acetoacetyl-CoA thiolase/HMG-CoA reductase and HMG-CoA synthase. Shown is the effect of hydrogen ion concentration on the conversion of acetyl-CoA to acetoacetyl-CoA ( ), of HMG-CoA to mevalonate ( ), and of acetyl-CoA to mevalonate (). All assays employed 50 mM sodium acetate, 50 mM glycine, 50 mM Tris, and 50 mM 2-(N-morpholino)ethanesulfonic acid at the indicated pH. Assays of acetoacetyl-CoA thiolase and HMG-CoA reductase activity were conducted essentially as previously described (11), but under the above conditions. For the conversion of acetyl-CoA to mevalonate, the additions were: 1 mM acetyl-CoA, 0.4 mM NADPH, 9 nM E. faecalis acetoacetyl-CoA thiolase/HMG-CoA reductase subunit, and 16 nM E. faecalis HMG-CoA synthase.
|
|
|
|---|
Analytical ultracentrifugation and gel filtration revealed that E. faecalis HMG-CoA synthase is a dimer and thus has the same multimeric state as other HMG-CoA synthases (14). Optimal activity occurred at 37°C in the presence of 2.0 mM MgCl2 (Fig. 4), which stabilizes acetoacetyl-CoA (9). The free energy of activation,
Ha, was 6,000 cal. A pKa of 8.8 was estimated from the effect of hydrogen ion concentration on activity (Fig. 4). This value is similar to the pKa of 8.6 reported for the avian enzyme (15) that was subsequently attributed to Glu95 and to its presumably hydrophobic environment (8). Glu95, and by inference its conjugate residue Glu78 of the E. faecalis enzyme, acts as a general acid during the condensation stage of the HMG-CoA synthase reaction (Fig. 5).
As for the avian enzyme (18), the stoichiometry of acetyl-CoA binding was 1.2 ± 0.2 per monomer and of covalent acetylation was 0.60 ± 0.02 per monomer (Table 3). The difference in stoichiometry may indicate that the presence of an acetyl-S-enzyme intermediate at one active site may induce conformational changes that preclude simultaneous formation of an acetyl-S-enzyme intermediate at the other site. Km for the hydrolysis of acetyl-CoA, a reaction that models the third or hydrolytic stage of the overall reaction, was 10 µM. The Vmax of 10 eu/mg and the specific activity of 6 µmol/min/mg of protein for E. faecalis HMG-CoA synthase are only twofold greater than those for the avian enzyme (Table 2). However, the 10 µM Kmapp for acetoacetyl-CoA, which is almost an order of magnitude higher than that for the avian enzyme, may be indicative of subtle differences at their active sites.
The overall conversion of acetyl-CoA to mevalonate comprises the first three reactions of the mevalonate pathway (Fig. 1). The coupled conversion of acetyl-CoA to mevalonate was demonstrated by using the dual enzyme acetoacetyl-CoA thiolase/HMG-CoA reductase and HMG-CoA synthase of E. faecalis. Optimal activity for the coupled reactions occurred at pH 8.5.
The enzymes of the mevalonate pathway of IPP biosynthesis represent potential targets for metabolic intervention. The mevalonate pathway is essential for the survival of S. aureus and, by inference, for other gram-positive bacteria (28). Although the mevalonate pathway is also essential for human subjects, there are two classes of HMG-CoA reductase that differ both with respect to their structure and their inhibition characteristics (4). The Ki values for statin drug inhibition of the class I HMG-CoA reductases of eukaryotes are nanomolar (2) but are millimolar for the class II HMG-CoA reductases of S. aureus (28) and E. faecalis (11). Significant differences also characterize the crystal structures of the class I human enzyme (12) and the class II enzyme of Pseudomonas mevalonii (13). It thus may be possible to develop inhibitors, i.e., "class II statins," specific to class II HMG-CoA reductases. Furthermore, the existence of two classes of one enzyme of the mevalonate pathway suggests that significant differences may also characterize the bacterial and human forms of additional enzymes of the pathway. Although the glutamate (8), cysteine (17), and histidine (15) implicated as participating in catalysis in the avian form of the enzyme are conserved in E. faecalis HMG-CoA synthase (Table 1), the bacterial HMG-CoA synthases and their animal counterparts exhibit only ca. 10% overall sequence identity. The sequences of bacterial HMG-CoA synthases also cluster away from those of the eukaryotic synthases (27). Although low sequence identity and remote clustering of the enzymes from different kingdoms are indicative of different classes of HMG-CoA synthase, this inference must await confirmation by detailed structural investigations.
We thank Michael Gwynn and Imogen Wilding of Glaxo SmithKline for the gift of E. faecalis genomic DNA and Kevin Lehnbeuter for technical assistance.
Journal paper 16732 from the Purdue Agricultural Experiment Station. ![]()
|
|
|---|
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»